Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020-06-01
|
| סדרה: | Journal of Microbiology, Immunology and Infection |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S168411822030092X |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|